PGE2 alleviates kidney and liver damage, decreases plasma renin activity and acute phase response in cirrhotic rats with acute liver damage

Experimental and Toxicologic Pathology

Volumn 56, Issue 4-5, 2005, Pages 291-303

  Rincón Sánchez, Ana Rosa ^a   Covarrubias, Amador ^b   Rivas Estilla, Ana María ^c   Pedraza Chaverrí, José ^d   Cruz, Cristino ^e   Islas Carbajal, María Cristina ^a   Panduro, Arturo ^f   Estanes, Alma ^e   Armendáriz Borunda, Juan ^a,b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b OPD Civil Hospital Juan I Menchaca   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^f HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

Author keywords

Acute liver damage; Decompensated cirrhosis; Experimental cirrhosis; Prostaglandin E2

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A1; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; FIBRINOGEN; MESSENGER RNA; OROSOMUCOID; PROSTAGLANDIN E2; ACUTE PHASE PROTEIN; RENIN;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY WALL; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; FATTY LIVER; GENE EXPRESSION; KIDNEY; KIDNEY FUNCTION; KIDNEY INJURY; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER INJURY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; RAT; SODIUM URINE LEVEL; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; EXPERIMENTAL LIVER CIRRHOSIS; LIVER; LIVER DISEASE; NORTHERN BLOTTING; PATHOLOGY; WISTAR RAT;

ACUTE-PHASE PROTEINS; ANIMALS; BLOTTING, NORTHERN; CARBON TETRACHLORIDE; DINOPROSTONE; GENE EXPRESSION; KIDNEY; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER DISEASES; MALE; RATS; RATS, WISTAR; RENIN;

EID: 14644424576     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2004.10.003     Document Type: Article

References (50)

1. P.G. Andreis, J.F. Whitfield, and U. Armato Stimulation of DNA synthesis and mitosis of hepatocytes in primary cultures of neonatal rat liver by arachidonic acid and prostaglandins Exp Cell Res 134 1981 265 272
2. H. Araki, and A.M. Lefer Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver Am J Physiol 238 1980 H176 H181
3. A.I. Arieff, and C.A. Chidsey Renal function in cirrhosis and the effects of prostaglandin A Am J Med 56 1974 695 703
4. V. Arroyo, R. Planas, and J. Gaya Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion Eur J Clin Invest 13 1983 271 278
5. V. Arroyo, P. Ginès, and A.L. Gerbes Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis International ascitis club. Hepatology 23 1996 164 176
6. H.U. Baer, T. Guastella, and A.M. Wheatley Acute effects of partial hepatectomy on liver blood flow in the jaundiced rats J Hepatol 19 1993 377 382
7. A. Banan, G.S. Smith, and C.L. Rieckenberg Protection against ethanol injury by prostaglandin in a human intestinal cell line role of microtubules Am J Physiol 274 1998 G111 G121
8. R. Bataller, P. Sort, and P. Ginès Hepatorenal syndrome definition, pathophysiology, clinical features and management Kidney Int 66 1998 S47 S53
9. M.D. Breyer, and R.M. Breyer Prostaglandin E receptors and the kidney Am J Physiol Renal Physiol 279 2000 F12 F23
10. 2 in thioacetamide-induced liver cirrhosis Exp Toxicol Pathol 49 1997 141 146
11. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid gunidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
12. A. Chutaputti Management of refractory ascites and hepatorenal syndrome J Gastroenterol Hepatol 17 2002 456 461
13. J.D. Clewell, and P. Walker-Renard Prostaglandins for the treatment of hepatorenal syndrome Ann Pharmacother 28 1994 54 55
14. D.C. Davis, W.Z. Potter, and D.J. Jollow Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen Life Sci 14 1974 2099 2109
15. M. Epstein, D.P. Berk, and N.K. Hollenberg Renal failure in the patient with cirrhosis the role of active vasoconstriction Am J Med 49 1970 175 185
16. A. Fabbri, G. Bianchi, and M. Brizi Effects of systemic prostaglandin E1 on hepatic amino acid-nitrogen metabolism in patients with cirrhosis Hepatology 27 1998 815 821
17. N. Fausto, A.D. Laird, and E.M. Webber Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration FASEB J 9 1995 1527 1536
18. J. Fevery, E. Van Cutsem, and F. Nevens Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration J Hepatol 11 1990 153 158
19. B.L. Fiebich, S. Schleicher, and O. Spleiss Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C J Neurochem 79 2001 950 958
20. 1 alpha in the course of liver cirrhosis Prostaglandins 53 1997 11 20
21. T. Geiger, T. Andus, and J. Klapproth Induction of rat acute-phase proteins by interleukin 6 in vivo Eur J Immunol 18 1988 717 721
22. 1 on renal hemodynamics, sodium, and water excretion Am J Physiol 213 1967 939 946
23. A. Kurtz, and C. Wagner Cellular control of renin secretion J Exp Biol 202 1999 219 225
24. G. Laffi, C. Smorlesi, and G. La Villa The possible role of prostaglandins in renal impairment in patients with chronic liver disease Ital J Gastroenterol 15 1983 256 258
25. G. Laffi, G. La Villa, and M. Pinzani Arachidonic acid derivatives and renal function in liver cirrhosis Semin Nephrol 17 1997 530 548
26. M. Lopez-Parra, J. Claira, and A. Planaguma Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites Br J Pharmacol 135 2002 891 900
27. S. Marinkovic, G.P. Jahreis, and G.G. Wong IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo J Immunol 142 1989 808 812
28. Y. Mizoguchi, H. Tsutsui, and K. Miyajima The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model Hepatology 7 1987 1184 1188
29. S. Moller, F. Bendtsen, and J.H. Henriksen Vasoactive substances in the circulatory dysfunction of cirrhosis Scand J Clin Lab Invest 61 2001 421 429
30. 2 and prostacyclin in decompensated liver disease and hepatorenal syndrome Gastroenterology 100 1991 1069 1077
31. 2) and a prostaglandin analogue BW245C on galactosamine-induced hepatic necrosis J Hepatol 2 1986 53 64
32. M. Ogawa, T. Mori, and Y. Mori Inhibitory effects of prostaglandin E1 on T-cell mediated cytotoxicity against isolated mouse liver cells Gastroenterology 94 1988 1024 1030
33. 2 Prog Lipid Res 20 1981 605 608
34. J. Pedraza-Chaverrí, C. Cruz, and M.T. Chavez Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention Rev Invest Clin 42 1990 210 216
35. J. Pedraza-Chaverrí, B. Herrero, and M.E. Ibarra-Rubio Lack of correlation between human serum angiotensin converting enzyme activity and the renin-angiotensin-aldosterone system Clin. Chim. Acta 190 1990 105 106
36. J. Pedraza-Chaverri, C. Cruz, and R. Hernandez-Pando Angiotensin I-converting enzyme activity in rats with carbon tetrachloride-induced acute renal failure Ren Fail 15 1993 19 26
37. R.S. Rappaport, and G.R. Dodge Prostaglandin E inhibits the production of human interleukin 2 J Exp Med 155 1982 943 948
38. 4 on renal function in cirrhotic and non-cirrhotic rats Exp Toxicol Pathol 51 1999 199 205
39. 2 in carbon tetrachloride induced acute hepatic injury in the rat Prostaglandins 32 1986 439 455
40. H.M. Siragy, T. Senbonmatsu, and T. Ichiki Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor J Clin Invest 104 1999 181 188
41. M.H. Sketch Jr., A. Whelton, and E. Schollmayer Prevention of contrast media-induced renal dysfunction with prostaglandin E1 a randomized, double-blind, placebo-controlled study Am J Ther 8 2001 155 162
42. P.S. Thomas Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose Proc Natl Acad Sci USA 77 1980 5201 5205
43. C. Wagner, M. Hinder, and B.K. Kramer Role of renal nerves in the stimulation of the renin system by reduced renal arterial pressure Hypertension 34 1999 1101 1105
44. M. Weinreb, A. Grosskopf, and N. Shir The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype Am J Physiol 276 1999 E376 E383
45. G. Wensing, R. Sabra, and R.A. Branch The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function Hepatology 11 1990 779 786
46. H. Yamane, Y. Sugimoto, and S. Tanaka Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils Biochem Biophys Res Commun 278 2000 224 228
47. R.D. Zipser, J.C. Hoefs, and P.F. Speckart Prostaglandins modulators of renal function and pressor resistance in chronic liver disease J Clin Endocrinol Metab 48 1979 895 900
48. 2 in the hepatorenal syndrome evidence for increased vasoconstrictor and decreased vasodilator factors Gastroenterology 84 1983 697 703
49. R.J. Zitnik, T. Zheng, and J.A. Elias cAMP inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts Am. J. Physiol. 264 1993 L253 L260
50. 1 Prostaglandins 13 1977 819 830